Sometimes, I have the same nightmare: my last insulin pen breaks, and all the hospitals are closed ... Changing the needle ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

Digital health tools, artificial intelligence (AI), and wearable devices are leading the way in transforming the landscape ...

Millions in South Africa face rising diabetes treatment costs and limited access to insulin pens, sparking protests.

In the world of health, Novo Nordisk stops insulin pen production, Trump's potential health appointments draw attention, and ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Traditionally, scientists believed that obesity led to type 2 diabetes by impairing insulin signaling within liver and fat ...

Weight loss drugs are incredibly sought-after, but they’re also often difficult to obtain due to limited insurance coverage ...

The international medical charity Doctors Without Borders has called on leading pharmaceutical corporations and "all insulin ...

Ahead of World Diabetes Day, Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, ...